Enzymatic resolution and cholinergic properties of (+/-)3-quinuclidinol derivatives.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002091:Butyrylcholinesterase / Q000097:blood; D002802:Cholinesterases / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006736:Horses; D007082:Ileum / Q000187:drug effects; D007700:Kinetics; D008297:Male; D010095:Oxotremorine; D011812:Quinuclidines / Q000494:pharmacology / Q000627:therapeutic use; D011869:Radioligand Assay; D051381:Rats; D011976:Receptors, Muscarinic / Q000378:metabolism; D012021:Reflex, Abnormal / Q000139:chemically induced / Q000188:drug therapy; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D011812:Quinuclidines; D011976:Receptors, Muscarinic; D010095:Oxotremorine; D002091:Butyrylcholinesterase; D002802:Cholinesterases